Tag Archives: lenvima

November, 2018

August, 2018

January, 2018

September, 2017

January, 2017

February, 2015

  • 13 February

    Eisai’s Thyroid Cancer Drug Receives Early FDA Approval

    The US Food and Drug Administration (FDA) has granted an early approval to Eisai’s drug for the most common form of thyroid cancer. The agency announced that it has approved the Japanese drugmaker’s Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive …